Befovacimab Antibody
Befovacimab (BAY 1093884) is a fully human monoclonal IgG2 antibody targeting tissue factor pathway inhibitor (TFPI) . It is a research tool for investigating haemophilia A and B, with studies exploring its potential to restore thrombin generation in both in vitro and in vivo models.
Product Specifications
Target
Others
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Protein Biochemistry
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
